Table 3.
Summary of characteristics of vectors used for glutamic acid decarboxylase expression in pain treatment (modulated from the report5)
HSV | AV | AAV vector | FV vector | |
---|---|---|---|---|
Wild type | DS-DNA | DS-DNA | SS-DNA | a |
Genome size (kb) | 152 | 36 | ∼4.7 | 13 |
Capacity of gene inserted (kb) | ∼40 | ∼7.5 | ∼4.5 | 9.2 |
Persistence of gene expression | Days–weeks | Days–weeks | Months–years | Days–weeks |
Safety issues | Immune and inflammatory response | Immune and inflammatory response | Insertional mutagenesis | Apathogenicb |